|Articles|April 15, 2002
- BioPharm International-04-01-2002
- Volume 15
- Issue 4
Advances in Amino Acid Analysis
Author(s)John C. Anders
by John C. Anders, AAI International With the advent of proteomics, innovative protein-based pharmaceuticals are entering the drug development pipeline. Compositional analysis, protein quantitation, and absorptivity determination by amino acid analysis ensures accurate characterization of recombinant proteins, amino acids, and peptides in development, bulk, and final products.
Advertisement
Articles in this issue
over 23 years ago
Analytical Advances: Paperless or Less Paper?over 23 years ago
Beyond QSITover 23 years ago
Determining Protein Concentration, Part 1: Methodologyover 23 years ago
Guest Editorial: The Protein Production Challengeover 23 years ago
Business Matters: Personalized Medicine or Blockbusterology?Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How Mitigation and Maintenance Protect Against Future Risk
2
FAQ: Milestones You May Have Missed in the 2025 Biopharma Pipeline
3
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
4
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
5
